BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 22890324)

  • 1. Silencing of miR-148a in cancer-associated fibroblasts results in WNT10B-mediated stimulation of tumor cell motility.
    Aprelikova O; Palla J; Hibler B; Yu X; Greer YE; Yi M; Stephens R; Maxwell GL; Jazaeri A; Risinger JI; Rubin JS; Niederhuber J
    Oncogene; 2013 Jul; 32(27):3246-53. PubMed ID: 22890324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of Microrna-148a in Cancer-Associated Fibroblasts from Oral Cancer Promotes Cancer Cell Migration and Invasion by Targeting Wnt10b.
    Min A; Zhu C; Peng S; Shuai C; Sun L; Han Y; Qian Y; Gao S; Su T
    J Biochem Mol Toxicol; 2016 Apr; 30(4):186-91. PubMed ID: 26709120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-148a suppressed cell invasion and migration via targeting WNT10b and modulating β-catenin signaling in cisplatin-resistant colorectal cancer cells.
    Shi L; Xi J; Xu X; Peng B; Zhang B
    Biomed Pharmacother; 2019 Jan; 109():902-909. PubMed ID: 30551544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-148a suppresses epithelial-mesenchymal transition and invasion of pancreatic cancer cells by targeting Wnt10b and inhibiting the Wnt/β-catenin signaling pathway.
    Peng L; Liu Z; Xiao J; Tu Y; Wan Z; Xiong H; Li Y; Xiao W
    Oncol Rep; 2017 Jul; 38(1):301-308. PubMed ID: 28586066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and the clinical significance of Wnt10a and Wnt10b in endometrial cancer are associated with the Wnt/β-catenin pathway.
    Chen H; Wang Y; Xue F
    Oncol Rep; 2013 Feb; 29(2):507-14. PubMed ID: 23135473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dectection and analysis of miRNA expression in breast cancer-associated fibroblasts].
    Zeng Z; Hu P; Tang X; Zhang H; Du Y; Wen S; Liu M
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Oct; 30(10):1071-5. PubMed ID: 25270211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of miR-31 and its target gene SATB2 in cancer-associated fibroblasts.
    Aprelikova O; Yu X; Palla J; Wei BR; John S; Yi M; Stephens R; Simpson RM; Risinger JI; Jazaeri A; Niederhuber J
    Cell Cycle; 2010 Nov; 9(21):4387-98. PubMed ID: 20980827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-148a is a downstream effector of X-box-binding protein 1 that silences Wnt10b during adipogenesis of 3T3-L1 cells.
    Cho YM; Kim TM; Hun Kim D; Hee Kim D; Jeong SW; Kwon OJ
    Exp Mol Med; 2016 Apr; 48(4):e226. PubMed ID: 27055562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA HOXA11-AS promotes migration and invasion through modulating miR-148a/WNT1/β-catenin pathway in gastric cancer.
    Guo T; Yuan X; Liu DF; Peng SH; Xu AM
    Neoplasma; 2020 May; 67(3):492-500. PubMed ID: 32009419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-141-3p suppresses gastric cancer induced transition of normal fibroblast and BMSC to cancer-associated fibroblasts via targeting STAT4.
    Zhou Y; Zhong JH; Gong FS; Xiao J
    Exp Mol Pathol; 2019 Apr; 107():85-94. PubMed ID: 30502321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of exosomal miR-148b from cancer-associated fibroblasts promotes endometrial cancer cell invasion and cancer metastasis.
    Li BL; Lu W; Qu JJ; Ye L; Du GQ; Wan XP
    J Cell Physiol; 2019 Mar; 234(3):2943-2953. PubMed ID: 30146796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-148a-3p suppresses epithelial-to-mesenchymal transition and stemness properties via Wnt1-mediated Wnt/β-catenin pathway in pancreatic cancer.
    Fu X; Hong L; Yang Z; Tu Y; Xin W; Zha M; Tu S; Sun G; Li Y; Xiao W
    J Cell Mol Med; 2020 Nov; 24(22):13020-13035. PubMed ID: 33026174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long Noncoding RNA HOXB-AS1 Is Upregulated in Endometrial Carcinoma and Sponged miR-149-3p to Upregulate Wnt10b.
    Liu D; Qiu M; Jiang L; Liu K
    Technol Cancer Res Treat; 2020; 19():1533033820967462. PubMed ID: 33073693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-543 Inhibits the Migration and Epithelial-To-Mesenchymal Transition of TGF-β-Treated Endometrial Stromal Cells via the MAPK and Wnt/β-Catenin Signaling Pathways.
    Wang L; Liu D; Wei J; Yuan L; Zhao S; Huang Y; Ma J; Yang Z
    Pathol Oncol Res; 2021; 27():1609761. PubMed ID: 34257616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant low expression of p85α in stromal fibroblasts promotes breast cancer cell metastasis through exosome-mediated paracrine Wnt10b.
    Chen Y; Zeng C; Zhan Y; Wang H; Jiang X; Li W
    Oncogene; 2017 Aug; 36(33):4692-4705. PubMed ID: 28394344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer-associated fibroblasts promote cancer cell growth through a miR-7-RASSF2-PAR-4 axis in the tumor microenvironment.
    Shen Z; Qin X; Yan M; Li R; Chen G; Zhang J; Chen W
    Oncotarget; 2017 Jan; 8(1):1290-1303. PubMed ID: 27901488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomal transfer of miR-124 inhibits normal fibroblasts to cancer-associated fibroblasts transition by targeting sphingosine kinase 1 in ovarian cancer.
    Zhang Y; Cai H; Chen S; Sun D; Zhang D; He Y
    J Cell Biochem; 2019 Aug; 120(8):13187-13201. PubMed ID: 30957275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The long noncoding RNA noncoding RNA activated by DNA damage (NORAD)-microRNA-496-Interleukin-33 axis affects carcinoma-associated fibroblasts-mediated gastric cancer development.
    Huang C; Liu J; He L; Wang F; Xiong B; Li Y; Yang X
    Bioengineered; 2021 Dec; 12(2):11738-11755. PubMed ID: 34895039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. lncRNA HOTAIRM1 regulates cell proliferation and the metastasis of thyroid cancer by targeting Wnt10b.
    Li C; Chen X; Liu T; Chen G
    Oncol Rep; 2021 Mar; 45(3):1083-1093. PubMed ID: 33650656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-222 reprogrammed cancer-associated fibroblasts enhance growth and metastasis of breast cancer.
    Chatterjee A; Jana S; Chatterjee S; Wastall LM; Mandal G; Nargis N; Roy H; Hughes TA; Bhattacharyya A
    Br J Cancer; 2019 Oct; 121(8):679-689. PubMed ID: 31481734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.